Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation.
第一作者:
Takeo,Arita
第一单位:
Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: takeo.arita@takeda.com.
作者:
主题词
转录激活因子4(Activating Transcription Factor 4);氨酰基tRNA合成酶类(Amino Acyl-tRNA Synthetases);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞死亡(Cell Death);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞存活(Cell Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);酶抑制剂(Enzyme Inhibitors);人类(Humans);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);分子结构(Molecular Structure);肿瘤, 实验性(Neoplasms, Experimental);吡啶羧酸类(Picolinic Acids);吡咯烷酮类(Pyrrolidinones);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.bbrc.2017.01.045
PMID
28087278
发布时间
2021-12-04
- 浏览11
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文